Stuart Atkinson

Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Assessing the Efficacy and Safety of Proton Pump Inhibitor Lansoprazole in Infants with Symptoms of Gastroesophageal Reflux Disease

Susan R. Orenstein, Eric Hassall, Wanda Furmaga-Jabłońska et al. · The Journal of Pediatrics · 2008 · 375 citations

Placebo-controlled Trial Assessing, Gastroenterology, Pediatrics +4

Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed‐release formulation – results from two randomized controlled studies

Prateek Sharma, Nicholas J. Shaheen, María Claudia Pérez et al. · Alimentary Pharmacology & Therapeutics · 2009 · 120 citations · Full text

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease

Ronnie Fass, William D. Chey, Salam Zakko et al. · Alimentary Pharmacology & Therapeutics · 2009 · 93 citations · Full text

Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials

Majid Vakily, Weijiang Zhang, Jingtao Wu et al. · Current Medical Research and Opinion · 2009 · 92 citations

AN OPEN, RANDOMISED, PARALLEL GROUP STUDY OF LACTULOSE VERSUS ISPAGHULA IN THE TREATMENT OF CHRONIC CONSTIPATION IN ADULTS

Michael Rouse, Nicola Chapman, M. Mahapatra et al. · International Journal of Clinical Practice · 1991 · 67 citations

Food Intolerance, Functional Gastrointestinal Disorder, Pharmacology +8